305 related articles for article (PubMed ID: 27058798)
21. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
22. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond
Bucerius J; Dijkgraaf I; Mottaghy FM; Schurgers LJ
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):251-265. PubMed ID: 30302506
[TBL] [Abstract][Full Text] [Related]
23. Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).
Buscombe JR
Br J Radiol; 2015 Sep; 88(1053):20140648. PubMed ID: 26110339
[TBL] [Abstract][Full Text] [Related]
24. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
MacAskill MG; Newby DE; Tavares AAS
Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
[TBL] [Abstract][Full Text] [Related]
25. Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
Boswijk E; Bauwens M; Mottaghy FM; Wildberger JE; Bucerius J
Methods; 2017 Nov; 130():90-104. PubMed ID: 28602809
[TBL] [Abstract][Full Text] [Related]
26. Is (18)F-FDG PET really a promising marker for clinically relevant atherosclerosis?
Brammen L; Palumbo B; Lupattelli G; Sinzinger H
Hell J Nucl Med; 2014; 17(1):62-3. PubMed ID: 24701595
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
[TBL] [Abstract][Full Text] [Related]
28. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
[TBL] [Abstract][Full Text] [Related]
29. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
Blomberg BA; Høilund-Carlsen PF
PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET imaging of atherosclerosis: Do we know what we see?
Sheikine Y; Akram K
Atherosclerosis; 2010 Aug; 211(2):371-80. PubMed ID: 20202637
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
32. Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on
Ernst D; Weiberg D; Baerlecken NT; Schlumberger W; Daehnrich C; Schmidt RE; Bengel FM; Derlin T; Witte T
Atherosclerosis; 2017 Apr; 259():12-19. PubMed ID: 28279832
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.
Miyagawa M; Yokoyama R; Nishiyama Y; Ogimoto A; Higaki J; Mochizuki T
Circ J; 2014; 78(6):1302-10. PubMed ID: 24817762
[TBL] [Abstract][Full Text] [Related]
34. Imaging atherosclerosis with positron emission tomography.
Joseph P; Tawakol A
Eur Heart J; 2016 Oct; 37(39):2974-2980. PubMed ID: 27125951
[TBL] [Abstract][Full Text] [Related]
35. Atherosclerosis imaging with
Høilund-Carlsen PF; Sturek M; Alavi A; Gerke O
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1538-1551. PubMed ID: 31773235
[TBL] [Abstract][Full Text] [Related]
36. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
[TBL] [Abstract][Full Text] [Related]
37. Comparison of [
Kim JM; Lee ES; Park KY; Seok JW; Kwon OS
JACC Cardiovasc Imaging; 2019 Feb; 12(2):370-372. PubMed ID: 30343085
[No Abstract] [Full Text] [Related]
38. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B
J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988
[TBL] [Abstract][Full Text] [Related]
39. PET imaging of inflammation in atherosclerosis.
Tarkin JM; Joshi FR; Rudd JH
Nat Rev Cardiol; 2014 Aug; 11(8):443-57. PubMed ID: 24913061
[TBL] [Abstract][Full Text] [Related]
40. Molecular imaging of coronary inflammation.
Pelletier-Galarneau M; Ruddy TD
Trends Cardiovasc Med; 2019 May; 29(4):191-197. PubMed ID: 30195945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
